Emily Warner

Principal Scientist • Ikarovec

Emily is a dedicated scientist with a rich and diverse background in molecular research and scientific outreach. Emily’s PhD explored the impact of flavonoid metabolites on endothelial function and vascular inflammation. Following her academic pursuits in diabetes at UEA and cardiovascular medicine at the University of Cambridge, Emily transitioned into pivotal roles at ikarovec, bringing her expert know-how of laboratory establishment, management, and leadership with a wealth of experience across the scientific spectra to develop and test novel gene therapies for common ophthalmic diseases. 


Also speaking

Ann-Hunter Van Kirk

Senior Equity Research Analyst Biopharmaceuticals • Bloomberg Intelligence

Jessica Berlier

Director P&AD • Catalent Cell & Gene Therapy

Michal Besser

Chief Technology Officer, Davidoff Cancer Center • Rabin Medical Center

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.